Anaerobic exercise capacity in patients with juvenile-onset idiopathic inflammatory myopathies
✍ Scribed by Takken, Tim ;van der Net, Janjaap ;Helders, Paul J. M.
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 76 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objective
To 1) report the feasibility of an “all‐out” 30‐second cycling exercise test (Wingate Anaerobic Exercise Test [WAnT]) in juvenile‐onset idiopathic inflammatory myopathy (JIIM) patients, 2) describe the anaerobic exercise capacity in juvenile dermatomyositis patients, and 3) determine if the anaerobic exercise capacity could be related to disease duration or disease phase.
Methods
Twenty patients (age 14.13 ± 5.4 years) with JIIM participated in this study. All patients were able to perform the WAnT without adverse events.
Results
Comparison with healthy controls revealed a −29.3 ± 26.58% (P = 0.001) and −27.6 ± 25.7% (P = 0.002) impairment in mean power and peak power on the WAnT, respectively. The WAnT correlated with disease phase and with knee extensor muscle strength.
Conclusion
The WAnT might be a valuable adjunct next to other assessment tools in the followup of JIIM patients.
📜 SIMILAR VOLUMES
## Abstract ## Objective To determine the long‐term outcome and associated clinical, serologic, and pathologic features in a cohort of patients with connective tissue disease (CTD) and the anti–signal recognition particle (anti‐SRP) autoantibody. ## Methods Sera and clinical data were collected
## Objective: To assess for novel markers of muscle damage using urinary muscle metabolites by 1h magnetic resonance spectroscopy in patients with juvenile idiopathic inflammatory myopathy (iim). ## Methods: Creatine (cr), choline (cho), betaine (bet), glycine (gly), trimethylamine oxide (tmao),
## Abstract ## Objective To investigate T cell receptor (TCR) expression in 3 different compartments that could be involved in patients with myositis: muscle, lung, and peripheral blood. ## Methods Nine patients with polymyositis (PM), dermatomyositis, or inclusion body myositis underwent bronch
## Abstract ## Objective To determine the prevalence of myositis‐specific autoantibodies (MSAs) and myositis‐associated autoantibodies (MAAs) and their clinical and immunogenetic correlations in Mediterranean patients with idiopathic inflammatory myopathies. ## Methods Sera from 88 patients were